Literature DB >> 29714145

The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine.

Gracia Montag1, Helga Stopper1, Quoc Anh Ngo2, Henning Hintzsche1,3.   

Abstract

BACKGROUND: Vinca alkaloids are important cancer drugs belonging to the class of antimitotic agents. The most commonly used substances are vinblastine and vincristine, other compounds are vinorelbine and vinflunine. All of them are very effective drugs but their use is limited by severe side-effects including neurotoxicity and bone marrow depression. Therefore, it is very important to develop novel vinca alkaloids with similar efficacy but lower toxicity.
METHODS: Here, we analyzed two new compounds, 4-chlorochablastine and 4-chlorochacristine, with regard to their biological activity. These novel compounds were applied to a leukemia cell line at clinically relevant concentrations. For comparison, the established vinca alkaloids vinblastine, vincristine, vinorelbine, and vinflunine were also tested.
RESULTS: Both novel substances decreased cellular proliferation. Apoptosis was found to be increased using two different methods reflecting early and late apoptosis. Cell cycle analysis revealed a clear decrease in G1-cells and an increase in G2/M-cells indicating an arrest in mitosis. In general, 4- chlorochablastine and 4-chlorochacristine caused these effects at concentrations higher than those needed for vinblastine, vincristine, and vinorelbine, but the potency was approximately in the range of vinflunine.
CONCLUSION: Taken together, the results show first indications that these novel vinca alkaloids might be effective and that they warrant further analysis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cytotoxicity; HL-60 cells; chlorochablastine; chlorochacristine; vinblastine; vinca alkaloids; vincristine; vinflunine; vinorelbine.

Mesh:

Substances:

Year:  2019        PMID: 29714145     DOI: 10.2174/1568009618666180430142233

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  1 in total

1.  Antiproliferative and antiinflammatory coxib-combretastatin hybrids suppress cell cycle progression and induce apoptosis of MCF7 breast cancer cells.

Authors:  Quoc Anh Ngo; Thuy Hang Nguyen Thi; Minh Quan Pham; Domenico Delfino; Thi Thao Do
Journal:  Mol Divers       Date:  2020-06-30       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.